What is the appropriate code(s) to report administration of intranasal esketamine, including physician attendance and supervision of monitoring by a clinical staff (eg, registered nurse)? This medication is given in the office setting following an assessment of the patients current condition; once given, observation of the patient is required to look for changes in physiological response or side-effect(s). ...
Subscribe or sign in to view the full article.
Article Overview
This premium article addresses coding considerations for office-based administration of intranasal esketamine. It is aimed at clinicians, coders, and billing staff who need to understand the general categories of evaluation and management, prolonged monitoring, and potential separate supply reporting discussed in the context of physician attendance and clinical staff supervision.
Why This Topic Matters
Intranasal esketamine administration can involve multiple service components in the same encounter. Understanding the broad coding categories and payer-related considerations helps users identify which parts of the visit may need separate review in the full article.
What You Will Learn
- How office-based medication administration encounters are discussed from a coding perspective
- What general service categories may be involved in monitoring and observation
- When supply reporting may be relevant depending on payer policy
- How physician attendance and clinical staff supervision are addressed at a high level
Who Should Read This
- Medical coders
- Billing staff
- Compliance professionals
- Physicians and other qualified health care professionals
- Clinical office administrators
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com